Feasibility of Targeted Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Patients Suspicious of Early-stage Lung Cancer - Trial NCT06301295
Access comprehensive clinical trial information for NCT06301295 through Pure Global AI's free database. This phase not specified trial is sponsored by Pusan National University Hospital and is currently Not yet recruiting. The study focuses on Lung Cancer. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pusan National University Hospital
Timeline & Enrollment
N/A
Mar 01, 2024
Dec 31, 2026
Primary Outcome
Genetic alteration with Next Generation Sequencing detection rate in intratumoral washing fluid
Summary
This is a single center, clinical trial evaluating the relevance of intratumoral washing for
 detection of generic alteration with Next Generation Sequencing.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06301295
Non-Device Trial